Menu
ABOUT
ABOUT
1
The main objective of the CorEuStem is to develop an efficient and effective consortium for harmonizing procedures, protocols and tools to provide efficient benchmarking, quality control and intensive training.
2
One of the major challenges for core facilities is to keep track, evaluate and implement cutting-edge technologies. Core facilities strive to standardize, evaluate, adopt and implement new technologies in the field of hPSCs, organoid biology and gene editing
3
In the past 12 years, experimental approaches used in biomedical research have been reshaped by the discovery of human induced pluripotent stem cells (iPSCs), the development of CRISPR/Cas9 gene editing technology and the possibility of generating in vitro organ-like structures called organoids.
Structure
Join the action
The COST Action CorEuStem welcomes research-active scientists working in the field. There are many ways to get involved.
News
Next CorEuStem webinar will be held November 9th, 2023, 11.00 – 12:00 (CET). Please register here to attend. Speaker: Dr. Leszek LisowskiChildren’s Medical Research Institute (CMRI)The University of Sydney, Australia Dr. Leszek Lisowski is a world vectorology expert with over 15 years of experience in developing and manufacturing viral vectors for human gene therapy. Currently,...
Please join us for the next webinar on “Preclinical testing of CRISPR therapeutics for inherited diseases”. Date: October 6th , 14.00h -15.00h (Berlin time) Speaker: Dr. rer. nat. Lukas Cyganek University Medical Center Göttingen, Germany Please register to attend at: https://forms.gle/zTPgawWQb9ryAdWC8 Participation by Zoom: To ensure that the meeting is accessible for all CorEuStem members. If you would...
Last weekend, on 9-10 September, it took place the first edition of CorEuStem hands-on iPSC training school at Erasmus Medical Center, in Rotterdam, The Netherlands. The course covered two days of talks and laboratory practice using human iPSC. Students from seven different countries learned how to thaw, split and cryopreserve iPSC, as well as manually...
We invite all CorEuStem members to participate in a two-day online seminar on the Fundamentals of human iPSC culture, September 9-10, 2023. Please register here to receive a Zoom link: https://forms.gle/JDVGf2AqC96S3k8J8 The seminar program can be fond here.
23 – 24 August 2023 Gene-editors from the CorEuStem network gathered for two days, discussing post-edit quality controls and molecular karyotyping cut-off strategies. The meeting took place at the Lund Stem Cell Centre, thanks to the organising skills of the CAGT team and WG2.
The Standardising Stem Cell Core Facilities in Europe – a CorEuStem Symposium took place at Champalimaud Foundation in Lisbon, Portugal, from 27th to 28th April 2023. The meeting gathered experts from the different core facilities in Europe and covered the latest advances in human stem cells and gene editing technologies. More than 80 participants members attended from CorEuStem COST Action. The two-day...
COST (European Cooperation in Science and Technology) is a funding organisation for research and innovation networks. Our Actions help connect research initiatives across Europe and beyond and enable researchers and innovators to grow their ideas in any science and technology field by sharing them with their peers. COST Actions are bottom-up networks with a duration of four years that boost research, innovation and careers.
The COST Action CorEuStem will be comprised of European core facilities that are experts in stem cell biology, differentiation, organoids and gene editing technologies with the aim of developing an efficient and effective consortium for harmonizing procedures and protocols across Europe and beyond.
MoU • Memorandum of Understanding
CSO Approval date: 25 May 2021
Action start date: 21 October 2021
Action end date: 20 October 2025
